QQQ   296.26 (+1.00%)
AAPL   145.93 (+1.37%)
MSFT   248.16 (+0.06%)
META   151.74 (+3.01%)
GOOGL   99.37 (+1.90%)
AMZN   102.24 (+3.04%)
TSLA   177.90 (+11.00%)
NVDA   203.65 (+2.84%)
NIO   12.71 (+4.44%)
BABA   118.38 (-1.82%)
AMD   75.40 (+0.32%)
T   19.95 (-0.25%)
MU   63.87 (+1.70%)
F   13.27 (+2.71%)
CGC   2.93 (+6.16%)
GE   83.23 (+2.58%)
DIS   109.54 (-0.15%)
AMC   5.51 (+4.36%)
PFE   43.79 (-1.04%)
PYPL   81.83 (+1.26%)
NFLX   360.77 (-1.12%)
QQQ   296.26 (+1.00%)
AAPL   145.93 (+1.37%)
MSFT   248.16 (+0.06%)
META   151.74 (+3.01%)
GOOGL   99.37 (+1.90%)
AMZN   102.24 (+3.04%)
TSLA   177.90 (+11.00%)
NVDA   203.65 (+2.84%)
NIO   12.71 (+4.44%)
BABA   118.38 (-1.82%)
AMD   75.40 (+0.32%)
T   19.95 (-0.25%)
MU   63.87 (+1.70%)
F   13.27 (+2.71%)
CGC   2.93 (+6.16%)
GE   83.23 (+2.58%)
DIS   109.54 (-0.15%)
AMC   5.51 (+4.36%)
PFE   43.79 (-1.04%)
PYPL   81.83 (+1.26%)
NFLX   360.77 (-1.12%)
QQQ   296.26 (+1.00%)
AAPL   145.93 (+1.37%)
MSFT   248.16 (+0.06%)
META   151.74 (+3.01%)
GOOGL   99.37 (+1.90%)
AMZN   102.24 (+3.04%)
TSLA   177.90 (+11.00%)
NVDA   203.65 (+2.84%)
NIO   12.71 (+4.44%)
BABA   118.38 (-1.82%)
AMD   75.40 (+0.32%)
T   19.95 (-0.25%)
MU   63.87 (+1.70%)
F   13.27 (+2.71%)
CGC   2.93 (+6.16%)
GE   83.23 (+2.58%)
DIS   109.54 (-0.15%)
AMC   5.51 (+4.36%)
PFE   43.79 (-1.04%)
PYPL   81.83 (+1.26%)
NFLX   360.77 (-1.12%)
QQQ   296.26 (+1.00%)
AAPL   145.93 (+1.37%)
MSFT   248.16 (+0.06%)
META   151.74 (+3.01%)
GOOGL   99.37 (+1.90%)
AMZN   102.24 (+3.04%)
TSLA   177.90 (+11.00%)
NVDA   203.65 (+2.84%)
NIO   12.71 (+4.44%)
BABA   118.38 (-1.82%)
AMD   75.40 (+0.32%)
T   19.95 (-0.25%)
MU   63.87 (+1.70%)
F   13.27 (+2.71%)
CGC   2.93 (+6.16%)
GE   83.23 (+2.58%)
DIS   109.54 (-0.15%)
AMC   5.51 (+4.36%)
PFE   43.79 (-1.04%)
PYPL   81.83 (+1.26%)
NFLX   360.77 (-1.12%)
NASDAQ:PNTG

The Pennant Group - PNTG Price Target & Analyst Ratings

$12.28
+0.10 (+0.82%)
(As of 01/27/2023 12:00 AM ET)
Add
Compare
Today's Range
$12.00
$12.49
50-Day Range
$9.73
$12.18
52-Week Range
$8.68
$20.28
Volume
78,069 shs
Average Volume
176,320 shs
Market Capitalization
$364.43 million
P/E Ratio
614.31
Dividend Yield
N/A
Price Target
$17.60

The Pennant Group Consensus Rating and Price Target (2023)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Analyst Rating

Hold
Based on 5 Analyst Ratings

Consensus Analyst Price Target

$17.60
43.32% Upside
High Prediction$22.00
Average Prediction$17.60
Low Prediction$14.00
TypeCurrent
1/27/22 to 1/27/23
1 Month Ago
12/28/21 to 12/28/22
3 Months Ago
10/29/21 to 10/29/22
1 Year Ago
1/27/21 to 1/27/22
Consensus Rating
Hold
Hold
Hold
Moderate Buy
Strong Buy
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
2 Buy rating(s)
2 Buy rating(s)
2 Buy rating(s)
2 Buy rating(s)
Hold
3 Hold rating(s)
3 Hold rating(s)
3 Hold rating(s)
1 Hold rating(s)
Sell
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
Consensus Price Target$17.60$17.60$19.80$34.00
Predicted Upside43.32% Upside24.98% Upside23.78% Upside28.89% Upside
Get The Pennant Group Upgrade and Downgrade Alerts

Sign-up to receive the latest news and ratings for PNTG and its competitors with MarketBeat's FREE daily newsletter.


PNTG Analyst Ratings By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

PNTG Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

The Pennant Group Stock vs. The Competition

TypeThe Pennant GroupMedical CompaniesS&P 500
Consensus Rating Score
2.40
2.64
2.46
Consensus RatingHoldBuyHold
Predicted Upside43.32% Upside1,078.33% Upside9.92% Upside
News Sentiment RatingPositive News
Positive News
Neutral News

Historical Target Prices and Ratings

DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
11/9/2022Stephens
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetEqual Weight$16.00 ➝ $14.00+25.45%
11/9/2022Royal Bank of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetOutperform$23.00 ➝ $18.00+52.93%
8/25/2022Oppenheimer
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Initiated CoverageOutperform$22.00+33.50%
8/10/2022Truist Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetHold$12.00 ➝ $18.00+4.65%
6/22/2022Stifel Nicolaus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetHold$18.00 ➝ $16.00+15.94%
6/18/2020SunTrust Banks
Subscribe to MarketBeat All Access for the recommendation accuracy rating
David S Macdonald
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingHold$28.00+13.59%
(Data available from 1/27/2018 forward. View 10+ years of historical ratings with our analyst ratings screener.)












PNTG Price Target - Frequently Asked Questions

What is The Pennant Group's consensus rating and price target?

According to the issued ratings of 5 analysts in the last year, the consensus rating for The Pennant Group stock is Hold based on the current 3 hold ratings and 2 buy ratings for PNTG. The average twelve-month price prediction for The Pennant Group is $17.60 with a high price target of $22.00 and a low price target of $14.00. Learn more on PNTG's analyst rating history.

Do Wall Street analysts like The Pennant Group more than its competitors?

Analysts like The Pennant Group less than other Medical companies. The consensus rating for The Pennant Group is Hold while the average consensus rating for medical companies is Buy. Learn more on how PNTG compares to other companies.

Does The Pennant Group's stock price have much upside?

According to analysts, The Pennant Group's stock has a predicted upside of 24.98% based on their 12-month price targets.

What analysts cover The Pennant Group?

The Pennant Group has been rated by Royal Bank of Canada, and Stephens in the past 90 days.


Stock Ratings Reports and Tools

This page (NASDAQ:PNTG) was last updated on 1/27/2023 by MarketBeat.com Staff